Cervical ripening before hysteroscopy.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: : Conscious patient satisfaction, hysteroscopic women, lack of nitroglycerin sensitivity, without cardiovascular disease lack of existence of severe bleeding, as well as unstable status
Exclusion criteria
Exclusion criteria: Systolic blood pressure less than ?100 mm Hg, intravascular volume reduction, valvular heart disease, severe bleeding, multiparous (NVD 2 = Gravid,) impossibility of using nitroglycerin based on anesthesiologist's sensitivity to any food preservative) Use of hypertension or cardiac drugs for cerebral hemorrhage, anemia, glaucoma, hyperthyroidism, heart problems, heart failure, liver and kidney disease, hypotension and dissatisfaction with continuing the company
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cervical ripening, bleeding measurment, gravidity, parity, abortion number andside Effects like vomiting, hypotension, dizziness, stomach pain, diarehea, fever. Timepoint: Before hysteroscopy and after using Medicine ?and Side Effects after using. Method of measurement: Cervical dilation with measured dilator, bleeding Mount :pad percentage, pain score, weight :kg, gravidity :pregnancy count/parity:living birth delivery, sideeffect like diarehea, flushinv, hypotension, dizziness, headache, fever, nausea ??? vomiting. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain score and Mount of bleeding and dilation after hysteroscopy. Timepoint: Before hysteroscopy and after medications. Method of measurement: Pad percentage, pain score? measurment of dilation with measured dilator bouji. | — |
Countries
Iran (Islamic Republic of)
Contacts
Iran University of Medical Sciences